eurocognitive functioning and functional connectivity in meningioma patients: a magnetoencephalography study
- Conditions
- brain tumorcancer10029211
- Registration Number
- NL-OMON30843
- Lead Sponsor
- Vrije Universiteit Medisch Centrum
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
(1) Adult (> 18 years), (2) histologically proven meningioma WHO grade I, (3) no clinical or radiological signs of tumor progression for at least one year prior to inclusion date, (4) end of treatment at least one year prior to inclusion, and (5) written informed consent.
Exclusion Criteria
(1) Use of centrally acting drugs, including corticosteroids, other than antiepileptic drugs, (2) a medical condition that interferes with normal cognitive functioning, (3) cerebrovascular pathology, (4) congenital CNS malformations, (5) multiple sclerosis, (6) Parkinson*s disease, (7) psychiatric disease or symptoms, (8) optic nerve meningiomas, (9) insufficient mastery of the Dutch language, and (10) inability to communicate adequately.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Main study parameters are cognitive functioning (measured by an extensive<br /><br>neuropsychological test battery) and MEG-measures of functional connectivity<br /><br>(synchronization likelihood). </p><br>
- Secondary Outcome Measures
Name Time Method <p>n.v.t.</p><br>